TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
Renal fibrosis, irrespective of its etiology, is a final common stage of almost all chronic kidney diseases. Increased apoptosis, epithelial-to-mesenchymal transition, and inflammatory cell infiltration characterize the injured kidney. On the molecular level, transforming growth factor-β1 (TGF-β1)-S...
Saved in:
Main Authors: | Agnieszka Loboda, Mateusz Sobczak, Alicja Jozkowicz, Jozef Dulak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2016/8319283 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology
by: Bart Krist, et al.
Published: (2015-01-01) -
Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-β/Smad Signaling Pathway
by: Chuang Gao, et al.
Published: (2021-01-01) -
UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway
by: Lijie Yang, et al.
Published: (2025-01-01) -
Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation
by: Guangzhuang Li, et al.
Published: (2025-01-01) -
miR‐130a‐3p regulated TGF‐β1‐induced epithelial‐mesenchymal transition depends on SMAD4 in EC‐1 cells
by: Xiaokang Tian, et al.
Published: (2019-03-01)